All News

ViewPoints: Eli Lilly outlines its oncology aspirations
Ref: ViewPoints Desk
Tags: ViewPointsLilly Clinical Research (R&D) Corporate Affairs Mergers & Acquisitions
Physician Views Poll Results: Key growth-driver watch - Sanofi, Regeneron's Dupixent should go from strength to strength
Ref: Physician Views Desk
Tags: Physician Views Poll ResultsSanofi RegeneronDermatitis Marketing & Sales Medical AffairsDupixent
TRELEGY ELLIPTA (fluticasone furoate, umeclidinium and vilanterol) PBS approved for the treatment of chronic obstructive pulmonary disease (COPD)
Ref: GlaxoSmithKline
Tags: Press ReleaseGSKCOPD PBSMarketing & Sales Regulatory AffairsTrelegy Ellipta
Eidos Therapeutics files for initial public offering
Ref: MarketWatch
Tags: NewsPointsEidos Therapeutics Corporate AffairsAG10
Update on Janssen’s BACE Inhibitor Program Regarding the Dominantly Inherited Alzheimer’s Network Trial (DIAN-TU)
Ref: Janssen
Tags: Press ReleaseJ&JDementia Clinical Research (R&D)atabecestat
Beactica Signs Three-Year Extension Agreement With Sanofi
Ref: PR Newswire
Tags: Press ReleaseBeactica SanofiDiabetes Corporate Affairsinsulin lispro
Allergy experts: "Clinical effect of ALK’s tree SLIT-tablet among the most significant ever seen in allergy immunotherapy trials"
Ref: GlobeNewswire
Tags: Press ReleaseALK-AbelloAllergies Clinical Research (R&D) Medical AffairsEAACI
Luye Pharma Acquires AstraZeneca’s Signature Products Seroquel and Seroquel XR
Ref: PR Newswire
Tags: Press ReleaseAstraZeneca Luye PharmaDepression Anxiety Schizophrenia and Bipolar Disorder Corporate Affairs Licensing Mergers & AcquisitionsSeroquel Seroquel XR
Johnson & Johnson to halt studies of Darzalex in combination with anti-PD-(L)1 therapies
Ref: GlobeNewswire
Tags: Top StoryGenmab J&JLung Cancer Myeloma Clinical Research (R&D)Darzalex JNJ-63723283 Tecentriq
ViaCyte to Present at the American Diabetes Association’s 78th Scientific Sessions
Ref: PR Newswire
Tags: Press ReleaseViaCyteDiabetes Clinical Research (R&D) Medical AffairsADAVC-01